Literature DB >> 24334795

Fecal microbiota therapy: ready for prime time?

Krishna Rao1, Vincent B Young, David M Aronoff.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24334795      PMCID： PMC4131295          DOI： 10.1086/674395

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  19 in total

1.  Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score.

Authors:  M R Welfare; L C Lalayiannis; K E Martin; S Corbett; B Marshall; J B Sarma
Journal:  J Hosp Infect       Date:  2011-11-01       Impact factor: 3.926

Review 2.  Gut microbiota in health and disease.

Authors:  Inna Sekirov; Shannon L Russell; L Caetano M Antunes; B Brett Finlay
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 3.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

4.  Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.

Authors:  Stuart Johnson; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2012-09-28       Impact factor: 9.079

5.  A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Authors:  Kevin W Garey; Shashank S Ghantoji; Dhara N Shah; Musarat Habib; Vaneet Arora; Zhi-Dong Jiang; Herbert L DuPont
Journal:  J Antimicrob Chemother       Date:  2011-09-21       Impact factor: 5.790

6.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

7.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen
Journal:  Lancet       Date:  2008-02-14       Impact factor: 79.321

8.  Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Lauren M De Leon; James B Watson; Colleen R Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382

9.  Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.

Authors:  Iris Figueroa; Stuart Johnson; Susan P Sambol; Ellie J C Goldstein; Diane M Citron; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

10.  Human gut microbiome viewed across age and geography.

Authors:  Tanya Yatsunenko; Federico E Rey; Mark J Manary; Indi Trehan; Maria Gloria Dominguez-Bello; Monica Contreras; Magda Magris; Glida Hidalgo; Robert N Baldassano; Andrey P Anokhin; Andrew C Heath; Barbara Warner; Jens Reeder; Justin Kuczynski; J Gregory Caporaso; Catherine A Lozupone; Christian Lauber; Jose Carlos Clemente; Dan Knights; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962
View more
  6 in total

1.  Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.

Authors:  J-C Lagier; M Delord; M Million; P Parola; A Stein; P Brouqui; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-07       Impact factor: 3.267

Review 2.  Fecal microbiota transplantation for the management of Clostridium difficile infection.

Authors:  Krishna Rao; Vincent B Young
Journal:  Infect Dis Clin North Am       Date:  2015-03       Impact factor: 5.982

Review 3.  Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection.

Authors:  Joshua Soto Ocaña; Nile U Bayard; Joseph P Zackular
Journal:  Curr Opin Microbiol       Date:  2021-12-08       Impact factor: 7.584

Review 4.  The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.

Authors:  Melinda M Pettigrew; J Kristie Johnson; Anthony D Harris
Journal:  Ann Epidemiol       Date:  2016-03-08       Impact factor: 3.797

Review 5.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection.

Authors:  Krishna Rao; Nasia Safdar
Journal:  J Hosp Med       Date:  2015-09-07       Impact factor: 2.960

6.  Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.

Authors:  Bruce E Hirsch; Nimit Saraiya; Kaitlin Poeth; Rebecca M Schwartz; Marcia E Epstein; Gerard Honig
Journal:  BMC Infect Dis       Date:  2015-04-17       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.